How HIV Research Reshaped Modern Medicine
Updated: 2024-11-29 14:00:03
Decades of scientific work turned the tide on a fatal disease and yielded insights into immunity, vaccines, and more- Decades of scientific work turned the tide on a fatal disease and yielded insights into immunity, vaccines, and more
Novel CAR TCell Therapy Obe-Cel Demonstrates High Response Rates in Adult Patients with Advanced B-Cell ALL
Updated: 2024-11-27 22:05:51Patients with relapsed or refractory CD19-positive B-cell acute lymphoblastic leukemia (ALL) who were treated with the novel anti-CD19 chimeric antigen receptor (CAR) T cell therapy, obecabtagene autoleucel (obe-cel), experienced high response rates and most did not need a subsequent stem cell transplant (SCT), according to results from the Phase Ib/II FELIX trial co-led by researchers at The University of Texas MD Anderson Cancer Center.Twice-Yearly Lenacapavir for PrEP Reduces HIV Infections by 96%
Updated: 2024-11-27 22:00:02
Rutgers Cancer Institute and RWJBarnabas Health to Unveil Pioneering Blood Cancer Research at the 66th American Society of Hematology Annual Meeting and Exposition
Updated: 2024-11-27 15:30:51
Physician-scientists from Rutgers Cancer Institute and RWJBarnabas Health will showcase a diverse range of hematology/oncology data from their clinical research program at the 66th American Society of Hematology (ASH) Annual Meeting and Exposition, being held in San Diego, California (and online) from December 7-10, 2024.For People Living with HIV/AIDS, TB is Still the Leading Cause of Death
Updated: 2024-11-27 15:00:54
The latest World Health Organization's Global Tuberculosis Report released in November 2024 painted a sobering picture; approximately 8.2 million people were newly diagnosed with TB in 2023, the highest number since the organization began global TB monitoring in 1995. TB is the leading cause of death among those with HIV /AIDS worldwide. According to the WHO, in 2023, 161,000 people died of HIV-associated TB.